BIOMAT Database Logo BIOMAT Database Logo

[Treatment of experimental hemorrhagic shock with a protease inhibitor: aprotinin]. 1979

J J Serrano, and G Uccelli, and M Liutkus, and M Boucard

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008297 Male Males
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012771 Shock, Hemorrhagic Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA. Hemorrhagic Shock
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
[A protease inhibitor and reversibility of hemorrhagic shock].
January 1968, Acta chirurgica Italica,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
[The protease inhibitor aprotinin in the therapy of septic shock].
December 1986, Harefuah,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
Protective action of a protease inhibitor in hemorrhagic shock.
June 1973, Archives internationales de pharmacodynamie et de therapie,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
[Treatment of chronic recurring parotitis with the protease inhibitor aprotinin (trasylol)].
April 1986, Laryngologie, Rhinologie, Otologie,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
Continuous enteral protease inhibition as a novel treatment for experimental trauma/hemorrhagic shock.
June 2022, European journal of trauma and emergency surgery : official publication of the European Trauma Society,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
TREATMENT OF EXPERIMENTAL HEMORRHAGIC SHOCK.
June 1964, BMQ; the Boston medical quarterly,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
Enteral administration of the protease inhibitor gabexate mesilate preserves vascular function in experimental trauma/hemorrhagic shock.
June 2023, Scientific reports,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
Energy metabolism and lysosomal events in hemorrhagic shock after aprotinin treatment.
January 1980, Circulatory shock,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
Effect of the proteinase inhibitor aprotinin in the management of hemorrhagic shock in the dog.
June 1978, American journal of veterinary research,
J J Serrano, and G Uccelli, and M Liutkus, and M Boucard
TREATMENT OF EXPERIMENTAL HEMORRHAGIC SHOCK IN DOGS WITH MITOCHONDRIA.
January 1964, Surgical forum,
Copied contents to your clipboard!